Q2 2024 Medicover AB Earnings Call Transcript
So good morning, everyone. Welcome to our second-quarter 2024 report, and welcome to you all. Our summary slide and our headline continued strong organic growth and cash generation. I think this is a very good quarter. We had a good first-quarter in the year and we follow up with an equally strong and solid second-quarter.
You are used to us growing, but nevertheless, 20% top-line growth or which share it had over 16% organic is significant considering the size of the company and our base. Importantly, this is solid across both divisions and within the divisions across our different businesses, there's nothing individual that stands out. Poland has been strong for a long time. Poland remains strong, and we expect that continue going forward.
We had continued good member intake in our corporate business, and we equally had very strong laboratory test growth were actually back on pre pandemic organic volume growth levels in diagnostics, which I think is a surprise to some of you. And it's a very good sign again, that's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |